125 related articles for article (PubMed ID: 24914721)
1. Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability.
Lu Y; Liu S; Zhao Y; Zhu L; Yu S
Acta Pharm; 2014 Jun; 64(2):211-22. PubMed ID: 24914721
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
5. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.
Stancanelli R; Ficarra R; Cannavà C; Guardo M; Calabrò ML; Ficarra P; Ottanà R; Maccari R; Crupi V; Majolino D; Venuti V
J Pharm Biomed Anal; 2008 Aug; 47(4-5):704-9. PubMed ID: 18400444
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
7. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
Zhang X; Zhang T; Lan Y; Wu B; Shi Z
AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
[TBL] [Abstract][Full Text] [Related]
8. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
Lin SY; Hsu CH; Sheu MT
J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
[TBL] [Abstract][Full Text] [Related]
10. Investigation of a fenofibrate-hydroxypropyl-beta-cyclodextrin system prepared by a co-grinding method.
Gu FG; Wang Y; Meng GD; Han HB; Wu CZ
Pharmazie; 2012 Feb; 67(2):143-6. PubMed ID: 22512084
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and in vivo evaluation of a formulation of dantrolene sodium with hydroxypropyl-β-cyclodextrin.
Chen M; Wu Q; Jiang J; Jin X; Liu S; Wang M; Zhao C
J Pharm Biomed Anal; 2017 Feb; 135():153-159. PubMed ID: 28027523
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, and thermal stability of β-cyclodextrin/soybean lecithin inclusion complex.
Wang X; Luo Z; Xiao Z
Carbohydr Polym; 2014 Jan; 101():1027-32. PubMed ID: 24299871
[TBL] [Abstract][Full Text] [Related]
14. Sufentanil-2-hydroxypropyl-β-cyclodextrin inclusion complex for pain treatment: physicochemical, cytotoxicity, and pharmacological evaluation.
Volobuef C; Moraes CM; Nunes LA; Cereda CM; Yokaichiya F; Franco MK; Braga AF; De Paula E; Tófoli GR; Fraceto LF; De Araujo DR
J Pharm Sci; 2012 Oct; 101(10):3698-707. PubMed ID: 22736497
[TBL] [Abstract][Full Text] [Related]
15. Preparation of natural borneol/2-hydroxypropyl-β-cyclodextrin inclusion complex and its effect on the absorption of tetramethylpyrazine phosphate in mouse.
Su J; Chen J; Li L; Li B; Shi L; Zhang H; Ding X
Chem Pharm Bull (Tokyo); 2012; 60(6):736-42. PubMed ID: 22689424
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
17. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
Hu L; Zhang H; Song W; Gu D; Hu Q
Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
[TBL] [Abstract][Full Text] [Related]
18. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin.
Mekjaruskul C; Yang YT; Leed MG; Sadgrove MP; Jay M; Sripanidkulchai B
Int J Pharm; 2013 Mar; 445(1-2):1-11. PubMed ID: 23376503
[TBL] [Abstract][Full Text] [Related]
19. Combination of β-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique.
Bourkaib N; Zhou J; Yao J; Fang Z; Mezghrani O
Drug Dev Ind Pharm; 2013 Jun; 39(6):918-27. PubMed ID: 22998295
[TBL] [Abstract][Full Text] [Related]
20. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
Wang L; Zeng F; Zong L
Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
